Company Filing History:
1 out of 832,880 Years Active: 2007
Title: The Innovative Journey of Sabine Amslinger
Introduction
Sabine Amslinger is a remarkable inventor based in Weiden, Germany, known for her contributions to the field of biochemistry. With a focus on the non-mevalonate isoprenoid pathway, she has developed innovative methods that enhance our understanding of enzymatic processes essential for various biochemical applications.
Latest Patents
Amslinger holds one patent titled "Intermediates and enzymes of the non-mevalonate isoprenoid pathway." This invention articulates a protein form that is capable of catalyzing the conversion of 2C-methyl-D-erythritol 2,4-cyclodiphosphate to 1-hydroxy-2-methyl-2-butenyl 4-diphosphate, particularly in its (E)-form. The patent further details the enzymatic conversion of 1-hydroxy-2-methyl-2-butenyl 4-diphosphate to isopentenyl diphosphate and/or dimethylallyl diphosphate. In addition, Amslinger’s work includes screening methods for inhibitors of these proteins and outlines chemical and enzymatic methods for the preparation of 1-hydroxy-2-methyl-2-butenyl 4-diphosphate.
Career Highlights
Throughout her career, Sabine Amslinger has dedicated her efforts to exploring intricate biochemical pathways. Her focus on enzyme functions and interactions has positioned her as a key player in the development of biotechnological applications.
Collaborations
Amslinger collaborates with notable scientists in her field, including Adelbert Bacher and Felix Rohdich. These partnerships enhance the innovative potential of her research and contribute to the advancement of knowledge in the biochemical community.
Conclusion
Sabine Amslinger's work exemplifies the spirit of innovation in the scientific realm. Her patented invention opens up new avenues for research and application in the field of isoprenoids, showcasing her impact as a leading inventor in biochemistry.